AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Convatec Group PLC

Declaration of Voting Results & Voting Rights Announcements May 31, 2023

4959_rns_2023-05-31_12ae90e7-2a10-4c9b-929b-4cf54d190134.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

Convatec Group PLC (CTEC)

Convatec Group PLC: Total Voting Rights

31-May-2023 / 10:06 GMT/BST


31 May 2023

Convatec Group Plc

("Convatec" or "the Company")

Total Voting Rights

The following notification is made in accordance with the UK Financial Conduct Authority's Disclosure and Transparency Rule 5.6.1. As at 31 May 2023, the Company's issued capital with voting rights consisted of 2,045,589,597 ordinary shares of 10p each (“Shares”). The Company does not hold any Shares in Treasury at the date of this disclosure.

The above figure (2,045,589,597) can be used by shareholders as the denominator for the calculations by which to determine if they are required to notify their interest in, or a change to, their interest in the Company under the UK Financial Conduct Authority's Disclosure and Transparency Rules. 

Enquiries

Grace McCalla, Assistant Company Secretary                                            +44(0)7575353388

[email protected] 

Convatec Group Plc’s LEI code is 213800LS272L4FIDOH92

About Convatec

Pioneering trusted medical solutions to improve the lives we touch: Convatec is a global medical products and technologies company, focused on solutions for the management of chronic conditions, with leading positions in advanced wound care, ostomy care, continence and critical care, and infusion care. With around 10,000 colleagues, we provide our products and services in almost 100 countries, united by a promise to be forever caring. Our solutions provide a range of benefits, from infection prevention and protection of at-risk skin, to improved patient outcomes and reduced care costs. Group revenues in 2022 were over $2 billion. The company is a constituent of the FTSE 100 Index (LSE: CTEC). To learn more about Convatec, please visit http://www.convatecgroup.com.


Dissemination of a Regulatory Announcement, transmitted by EQS Group.

The issuer is solely responsible for the content of this announcement.


ISIN: GB00BD3VFW73
Category Code: TVR
TIDM: CTEC
LEI Code: 213800LS272L4FIDOH92
Sequence No.: 247622
EQS News ID: 1645963
End of Announcement EQS News Service

fncls.ssp?fn=show_t_gif&application_id=1645963&application_name=news&site_id=fca

Talk to a Data Expert

Have a question? We'll get back to you promptly.